Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Net Income (2021 - 2025)

Historic Net Income for Molecular Partners Ag (MOLN) over the last 5 years, with Q3 2025 value amounting to -$15.1 billion.

  • Molecular Partners Ag's Net Income fell 11505936388.39% to -$15.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.0 billion, marking a year-over-year decrease of 2410271665.74%. This contributed to the annual value of -$61.4 million for FY2024, which is 1208.85% up from last year.
  • Per Molecular Partners Ag's latest filing, its Net Income stood at -$15.1 billion for Q3 2025, which was down 11505936388.39% from $4.7 million recorded in Q2 2025.
  • Molecular Partners Ag's Net Income's 5-year high stood at $165.2 billion during Q1 2022, with a 5-year trough of -$16.3 billion in Q1 2023.
  • Moreover, its 5-year median value for Net Income was -$17253.2 (2025), whereas its average is $6.3 billion.
  • In the last 5 years, Molecular Partners Ag's Net Income surged by 90218183697.23% in 2022 and then tumbled by 11505936388.39% in 2025.
  • Quarter analysis of 5 years shows Molecular Partners Ag's Net Income stood at -$68.7 million in 2021, then soared by 277.85% to $122.2 million in 2022, then crashed by 100.77% to -$939914.8 in 2023, then surged by 977.59% to $8.2 million in 2024, then crashed by 182641.67% to -$15.1 billion in 2025.
  • Its Net Income was -$15.1 billion in Q3 2025, compared to $4.7 million in Q2 2025 and -$17253.2 in Q1 2025.